D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
CALL
Factset
FDS
$10B
| $1.78M | ﹤0.01% |
+4,500
| New | +$1.64M |
|
|
UMPQ
3002
DELISTED
Umpqua Holdings Corp
UMPQ
| $1.77M | ﹤0.01% |
87,410
-27,896
| -24% | -$535K |
|
3003
Five Below
FIVE
$11.6B
| $1.77M | ﹤0.01% |
9,995
-100,451
| -91% | -$20M |
|
3004
Dorian LPG
LPG
$1.96B
| $1.76M | ﹤0.01% |
142,217
+57,062
| +67% | +$713K |
|
3005
Materion
MTRN
$3.94B
| $1.76M | ﹤0.01% |
25,712
+1,118
| +5% | +$80K |
|
3006
Matrix Service
MTRX
$312M
| $1.76M | ﹤0.01% |
168,771
-49,159
| -23% | -$527K |
|
|
ANAT
3007
DELISTED
American National Group, Inc. Common Stock
ANAT
| $1.76M | ﹤0.01% |
9,337
-14,447
| -61% | -$2.57M |
|
3008
CALL
American Eagle Outfitters
AEO
$2.94B
| $1.76M | ﹤0.01% |
68,200
-6,400
| -9% | -$203K |
|
3009
Sturm, Ruger & Co
RGR
$603M
| $1.76M | ﹤0.01% |
+23,855
| New | +$1.85M |
|
|
GTM
3010
CALL
ZoomInfo Technologies
GTM
$1.03B
| $1.76M | ﹤0.01% |
+28,700
| New | +$1.72M |
|
3011
Simmons First National
SFNC
$3.39B
| $1.75M | ﹤0.01% |
+59,268
| New | +$1.67M |
|
3012
First Merchants
FRME
$2.69B
| $1.75M | ﹤0.01% |
41,823
+20,657
| +98% | +$840K |
|
|
ACBA
3013
DELISTED
Ace Global Business Acquisition Ltd
ACBA
| $1.75M | ﹤0.01% |
+172,259
| New | +$1.72M |
|
3014
Alignment Healthcare
ALHC
$3.78B
| $1.75M | ﹤0.01% |
109,427
+20,483
| +23% | +$396K |
|
|
AXON
3015
Axon Enterprise
AXON
$42.8B
| $1.75M | ﹤0.01% |
+9,987
| New | +$1.81M |
|
3016
MaxLinear
MXL
$5.19B
| $1.75M | ﹤0.01% |
35,483
-3,661
| -9% | -$177K |
|
3017
iQIYI
IQ
$1.19B
| $1.75M | ﹤0.01% |
217,605
-1,769,008
| -89% | -$18.3M |
|
3018
Mercer International
MERC
$40.5M
| $1.74M | ﹤0.01% |
150,524
+33,082
| +28% | +$384K |
|
|
OTRK
3019
DELISTED
Ontrak
OTRK
| $1.74M | ﹤0.01% |
1,926
+1,797
| +1,393% | +$3.21M |
|
|
AJRD
3020
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $1.74M | ﹤0.01% |
39,861
| – | – |
|
|
PVG
3021
DELISTED
PRETIUM RESOURCES INC.
PVG
| $1.73M | ﹤0.01% |
179,643
-297,982
| -62% | -$2.84M |
|
3022
CALL
Dow Inc
DOW
$22B
| $1.73M | ﹤0.01% |
30,000
| – | – |
|
|
LTRPA
3023
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $1.72M | ﹤0.01% |
556,756
-155,836
| -22% | -$580K |
|
|
SLCR
3024
DELISTED
Silver Crest Acquisition Corporation Class A Ordinary Share
SLCR
| $1.72M | ﹤0.01% |
174,878
| – | – |
|
|
EUCR
3025
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
| $1.72M | ﹤0.01% |
175,681
+54,646
| +45% | +$533K |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.